Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Clinical Reasoning: A 2-Day-Old Boy With Sudden Cardiac Arrest and Encephalopathy.

  • Read more about Clinical Reasoning: A 2-Day-Old Boy With Sudden Cardiac Arrest and Encephalopathy.

Seizure Control in Neonates Undergoing Screening vs Confirmatory EEG Monitoring.

  • Read more about Seizure Control in Neonates Undergoing Screening vs Confirmatory EEG Monitoring.

Reader response: Child neurology in the 21st century: More than the sum of our RVUs.

  • Read more about Reader response: Child neurology in the 21st century: More than the sum of our RVUs.

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

  • Read more about Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Single-center series of boys with recurrent strokes and rotational vertebral arteriopathy.

  • Read more about Single-center series of boys with recurrent strokes and rotational vertebral arteriopathy.

Pediatric Multiple Sclerosis Severity Score in a large US cohort.

  • Read more about Pediatric Multiple Sclerosis Severity Score in a large US cohort.

Spectrum of cerebral arteriopathies in children with arterial ischemic stroke.

  • Read more about Spectrum of cerebral arteriopathies in children with arterial ischemic stroke.

Quantifying “Clinically Meaningful Changes” in Seizure Frequency - Data from Three Phase 3 Studies of ZX008 (Fenfluramine Hydrochloride Oral Solution) in Dravet Syndrome: Do Expectations and Views Change Over Time? (2247).

  • Read more about Quantifying “Clinically Meaningful Changes” in Seizure Frequency - Data from Three Phase 3 Studies of ZX008 (Fenfluramine Hydrochloride Oral Solution) in Dravet Syndrome: Do Expectations and Views Change Over Time? (2247).

Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study (4684).

  • Read more about Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study (4684).

Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?

  • Read more about Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to Neurology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List